Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BI-3406 is an orally active, highly potent and selective between KRAS and Son of Sevenless 1 (SOS1) interaction inhibitor(IC50 : 6 nM),with anticancer activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 67.00 | |
5 mg | In stock | $ 163.00 | |
10 mg | In stock | $ 263.00 | |
25 mg | In stock | $ 488.00 | |
50 mg | In stock | $ 698.00 | |
100 mg | In stock | $ 968.00 | |
500 mg | In stock | $ 1,930.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 178.00 |
Description | BI-3406 is an orally active, highly potent and selective between KRAS and Son of Sevenless 1 (SOS1) interaction inhibitor(IC50 : 6 nM),with anticancer activity. |
Targets&IC50 | KRAS-SOS1:6 nM |
Molecular Weight | 462.46 |
Formula | C23H25F3N4O3 |
CAS No. | 2230836-55-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 95 mg/mL (205.42 mM), Sonication is recommended.
Ethanol: 100 mg/mL (216.23 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BI-3406 2230836-55-0 GPCR/G Protein MAPK p38 MAPK Ras KRAS interaction anticancer Inhibitor BI 3406 inhibit Son Sevenless BI3406 GTP-loaded orally SOS1 inhibitor